These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 3010492)
1. Influence of granulocyte elastase-like proteinase (ELP) on platelet functions. Taki M; Miura T; Inagaki M; Tomita Y; Saito N; Okada Y; Tsuda Y; Meguro T; Yamada K Thromb Res; 1986 Mar; 41(6):837-46. PubMed ID: 3010492 [TBL] [Abstract][Full Text] [Related]
2. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related]
3. Role of thromboxane A2. Ambler J; Birch J; Maguire ED; Wallis RB Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695 [No Abstract] [Full Text] [Related]
4. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam. Romstedt K; Huzoor-Akbar Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062 [TBL] [Abstract][Full Text] [Related]
5. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin. Tandon NN; Ordinas A; Jamieson GA Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815 [TBL] [Abstract][Full Text] [Related]
6. Unexpected effects of aurin tricarboxylic acid on human platelets. Kinlough-Rathbone RL; Packham MA Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166 [TBL] [Abstract][Full Text] [Related]
7. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction. Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942 [TBL] [Abstract][Full Text] [Related]
8. Plasmin inhibition of platelet function and of arachidonic acid metabolism. Schafer AI; Adelman B J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones. Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351 [TBL] [Abstract][Full Text] [Related]
10. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction. Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612 [TBL] [Abstract][Full Text] [Related]
11. Effects of etamsylate on platelet functions and arachidonic acid metabolism. Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder. Patel YM; Patel K; Rahman S; Smith MP; Spooner G; Sumathipala R; Mitchell M; Flynn G; Aitken A; Savidge G Blood; 2003 Jun; 101(12):4828-35. PubMed ID: 12609843 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets. Matsuoka I; Nakahata N; Nakanishi H Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181 [TBL] [Abstract][Full Text] [Related]
14. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides. Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926 [TBL] [Abstract][Full Text] [Related]
15. XC 386: a new antiplatelet agent. Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition. Fenn CG; Littleton JM Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995 [TBL] [Abstract][Full Text] [Related]
17. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H; Stegmeier K Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261 [TBL] [Abstract][Full Text] [Related]
18. [Effect of heparin on platelet aggregation in vitro]. RĂ³ka L; Isert D Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949 [TBL] [Abstract][Full Text] [Related]
19. Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin. Sweatt JD; Johnson SL; Cragoe EJ; Limbird LE J Biol Chem; 1985 Oct; 260(24):12910-9. PubMed ID: 2997148 [TBL] [Abstract][Full Text] [Related]
20. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. Krishnamurthi S; Joseph S; Kakkar VV Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]